Vice President of Bioprocessing and Applications, MicrofluidX
James is the Head of Bioprocessing at MicrofluidX, where they are developing a microfluidics-based cell and gene therapy bioprocessing and manufacturing platform.
James has experience in cell and gene therapy process development and manufacturing optimisation. His work has focused on understanding the translational requirements for robust product realisation, considering aspects such as process development, manufacturability and ultimately the clinical adoption and health economic implications.
His technical experience has been focused on GMP protocol adaptation and the translational work required for GMP manufacturing of cell and gene therapies. Additionally, James has a background in Medicinal Chemistry, International Business and Health economics.
Stevenage Bioscience Catalyst30 November 2023